10/02/2026
This is a long read! But such a good one! Educational purposes only!
Natural medicine doesn’t have BLACK BOX warnings!
Alzheimer's Doesn't Just Happen. It's Prescribed.
By Charity Berry

I need you to read this. Not skim it. Not save it for later. Actually read it.
Because I have been doing this work for over a decade now, talking to hundreds of people, watching customers come to me after decades of pharmaceutical dependency — exhausted, foggy, struggling with memory, with mood, with everything — and when I dig into what they've been taking, I want to scream. Not at them. Never at them. At a system that handed them a pill for every complaint and called it medicine.
I feel inadequate sometimes, I'll be honest. Like no matter how clearly I explain this, how much research I share, how many real people I talk to who've been harmed — it still doesn't land the way it needs to. People hear "Benadryl causes Alzheimer's" and they think, Charity is being dramatic. It's an allergy pill. It's harmless. I've taken it my whole life.
That's exactly the problem.
The drugs I'm about to walk you through are not obscure medications. They are not experimental. They are the ones your doctor prescribes without hesitation, the ones you pick up at Walgreens without a second thought, the ones people take for years — sometimes decades — without ever being told what the research says about what they're doing to your brain.
And the research is damning. Peer-reviewed, published in JAMA, the BMJ, Neurology — the most respected medical journals in the world. This is not fringe science. This is not a conspiracy theory. This is what the literature says, and it's being ignored every single day in doctor's offices across this country.
Let's go through all seven. I am going to explain exactly what each drug does mechanically to your brain cells — not just the statistics, but the biology — because once you understand how something breaks, you can't un-know it.

1. Proton Pump Inhibitors (PPIs) — Omeprazole, Pantoprazole, Prilosec, Nexium
Prescribed for: Acid reflux, GERD, ulcers
Let me tell you how many people I know who have been on a PPI for years. A decade. Fifteen years. Prescribed "as needed" — which in practice means every single day, because the moment you stop taking it, the rebound acid is so severe that stopping feels impossible. That rebound isn't a coincidence. It's a feature, not a bug.
Here's what PPIs actually do: they suppress stomach acid by blocking the hydrogen-potassium ATPase enzyme in your stomach's parietal cells. No acid = no vitamin B12 absorption. B12 requires acid to be cleaved from food proteins. No acid, no B12. And because B12 stores can last a few years before depletion becomes obvious, you can be on a PPI for 3-4 years before the damage starts to show.
Now here's where it connects directly to your brain. B12 is essential for myelin sheath production — the protective coating around every single nerve fiber in your brain and spinal cord. It's also critical for the methylation cycle, which controls homocysteine metabolism. When B12 drops, homocysteine rises. Elevated homocysteine is one of the most well-established independent risk factors for Alzheimer's disease and accelerated brain atrophy.
But it doesn't stop there. PPIs have also been shown to cross the blood-brain barrier and directly inhibit the vacuolar-type H+-ATPase (v-ATPase) enzyme in brain lysosomes — the cellular cleaning system responsible for clearing amyloid-beta. When lysosomal function is impaired, amyloid plaques accumulate. This is not a side effect mentioned on the label. This is published mechanistic research.
The study: Gomm et al., published in JAMA Neurology in 2016, followed over 73,000 patients aged 75 and older. Those who used PPIs regularly had a 44% increased risk of dementia compared to non-users. The risk was dose- and duration-dependent — meaning the longer you take it, the worse it gets.
Forty-four percent. For heartburn medicine.

2. Fat-Soluble Statins — Simvastatin (Zocor), Atorvastatin (Lipitor), Lovastatin
Prescribed for: High cholesterol, cardiovascular disease prevention
I understand this one is going to upset people. Statins are one of the most prescribed drugs on earth. Billions of people take them. Doctors genuinely believe they are doing good. But what happens when you apply that drug long-term, with no consideration of what cholesterol actually does in the brain?
Here is the fundamental fact that the entire statin conversation ignores: your brain is approximately 60% fat by dry weight, and 25% of all the cholesterol in your body is in your brain. Cholesterol is not the enemy. In the brain, it is structural and functional. Every neuron depends on cholesterol-rich membranes to function. Myelin is largely cholesterol. Synaptic transmission — the process by which your neurons communicate — requires cholesterol. The brain makes its own cholesterol through a process called in situ synthesis, largely independent of dietary or circulating cholesterol. It has to. The brain is extraordinarily sensitive to cholesterol availability.
Fat-soluble statins — specifically simvastatin and atorvastatin — cross the blood-brain barrier. When they enter the brain, they inhibit HMG-CoA reductase the same way they do in the liver. The result is reduced cholesterol synthesis inside the brain itself. Cut the supply of cholesterol to a system that depends on it for every cell membrane, every synapse, and every myelin repair process — and you get degradation. Slowly. Progressively.
Multiple cohort studies have shown that long-term statin use is associated with higher rates of Alzheimer's disease. A 2009 study in Pharmacoepidemiology and Drug Safety found increased dementia incidence with prolonged statin exposure. A 2015 analysis in the Journal of Alzheimer's Disease found similar associations, particularly with lipophilic (fat-soluble) statins compared to hydrophilic ones like rosuvastatin or pravastatin, which don't cross the blood-brain barrier as readily.
There are also documented cases of "statin-associated cognitive impairment" — memory loss, word-finding difficulty, confusion — that resolve when the drug is discontinued. The FDA added cognitive impairment as a reported adverse event to all statin labels in 2012. And yet the conversation about long-term brain risk almost never happens in a cardiologist's office.

3. Benzodiazepines and Sleeping Pills — Xanax, Ativan, Va**um, Ambien, Lunesta
Prescribed for: Anxiety, insomnia, panic disorders
This is the one that breaks my heart, because so many of the women I talk to have been on these for years. Prescribed after a traumatic event. Prescribed for post-partum anxiety. Prescribed for the menopause insomnia that nobody wants to address the root cause of. And once you're on them, getting off is a nightmare — the withdrawal is medically dangerous, requiring a careful taper over months. So people stay on them. For years. For a decade. And their doctors keep refilling.
What benzodiazepines do in the brain is potentiate GABA — the inhibitory neurotransmitter. They essentially sedate the nervous system by making GABA receptors more responsive. This is why they work so effectively for anxiety and sleep in the short term. The problem is that the brain compensates: it downregulates its own GABA production and receptor sensitivity in response to the drug. This is how dependence forms. Remove the drug and you have a nervous system that has forgotten how to inhibit itself — hence the seizure risk in benzo withdrawal.
But the dementia connection goes deeper than receptor adaptation. Long-term benzodiazepine use has been linked to measurable reduction in hippocampal volume — the hippocampus being the brain structure most critical for forming new memories and the first structure that deteriorates in Alzheimer's disease. This isn't anecdotal. MRI studies have documented it.
The landmark study: Billioti de Gage et al., published in the BMJ in 2014, analyzed 1,796 cases of Alzheimer's disease. People who had used benzodiazepines for 3 months or longer had a 51% higher risk of developing Alzheimer's. The risk increased with duration and dose. The same research group published follow-up data confirming the association and demonstrating that the risk persisted even when accounting for anxiety and insomnia as confounders — meaning it's the drug itself, not the underlying condition, driving the risk.
51% higher risk. For something millions of people take every night to sleep.

4. Anticholinergics — Benadryl, Ditropan, Older Antidepressants (Amitriptyline, Doxepin), Antihistamines
Prescribed for: Allergies, sleep, urinary incontinence, depression.
I'm going to spend extra time here, because I genuinely believe this is one of the most under-discussed drug hazard in America. And it's not a prescription issue — you can walk into any pharmacy right now and buy diphenhydramine (Benadryl, NyQuil , Unisom) without talking to a single person. Parents give it to their children. People take it every night as a sleep aid. It is perceived as one of the safest medications available.
It is not safe for your brain with repeated use. Full stop.
Anticholinergics block acetylcholine — the primary neurotransmitter responsible for memory, attention, learning, and executive function. This is not a subtle effect. Acetylcholine is so central to memory that a deficiency in cholinergic neurons is considered one of the core features of Alzheimer's disease pathology. In fact, the most common class of Alzheimer's drugs (like donepezil) works by preventing the breakdown of acetylcholine — because preserving it helps maintain cognitive function. Anticholinergics do the exact opposite: they block it entirely.
With each exposure, you are chemically suppressing the very neurotransmitter system that encodes memory. Occasional use — one Benadryl for an acute allergic reaction — is unlikely to cause lasting damage in a healthy young person. But cumulative exposure over years? The research is unambiguous.
The study: Coupland et al., published in JAMA Internal Medicine in 2019, analyzed data from 284,000 patients — one of the largest studies of its kind. Cumulative anticholinergic use over three or more years was associated with a 50% increase in dementia risk. Separately, Gray et al. in JAMA Internal Medicine (2015) found that people who had taken anticholinergics for more than 3 years had a 54% increased risk of developing dementia, with the risk persisting even after the drugs were stopped — suggesting the neurological damage may be lasting rather than reversible.
Let me say that again. The risk persisted after they stopped taking the drug. This is not a temporary chemical effect. This is structural brain change.

5. Metformin — Treating a Disease That Doesn't Have to Exist
Prescribed for: Type 2 diabetes, pre-diabetes, PCOS
Let me say something that the medical system will not say to your face: type 2 diabetes is a dietary disease. It is caused by decades of excess processed carbohydrates, refined sugars, and seed oils driving chronic insulin resistance and pancreatic exhaustion. And it can be reversed — not managed, reversed — through correct dietary intervention, often within weeks to a couple of months. People do it every day. The research on low-carbohydrate, ketogenic and even carnivore diets for type 2 diabetes reversal is extensive, documented and consistently ignored by mainstream medicine in favor of lifetime pharmaceutical management.
Instead of addressing the cause, the standard of care is to prescribe metformin and tell the patient to "watch their carbs" — while offering no real guidance on what that actually means. And then they take metformin for twenty years. For a disease that didn't have to persist past month two.
That fundamental failure is the backdrop for what I'm about to tell you about metformin and your brain.
Metformin inhibits the absorption of vitamin B12 in the small intestine by interfering with calcium-dependent membrane action. Studies show that 10–30% of long-term metformin users develop B12 deficiency, with some research suggesting the rate is even higher at higher doses. The deficiency is gradual and often subclinical — meaning your B12 levels may appear "in range" on a standard lab panel while still being functionally inadequate for neurological health.
And as I explained in the PPI section: B12 deficiency has catastrophic consequences for the brain. Myelin degradation. Elevated homocysteine. Accelerated brain atrophy. A 2019 study published in Diabetes Care found that metformin users with B12 deficiency had significantly greater brain volume loss compared to non-deficient metformin users and non-users — accelerated neurodegeneration, measurable on imaging.
So here is what is happening: a person develops type 2 diabetes — a condition rooted in what they eat — is prescribed a drug instead of real dietary intervention, takes that drug for decades, and in the process quietly depletes the vitamin their brain depends on for structural integrity. Their brain atrophies. Their memory fades. And it gets filed under "Alzheimer's."
This is not bad luck. This is a predictable, preventable outcome of a system that profits from managing disease rather than resolving it.

6. SSRIs — Long-Term Use (5+ Years)
Prescribed for: Depression, anxiety, OCD, PTSD
The same pattern plays out here. Prescribed for a specific crisis moment, then refilled month after month, year after year, while the underlying causes — grief, trauma, chronic stress, hormonal imbalance, nutritional deficiency — are never addressed. Decade-long, indefinite maintenance use carries a neurological risk profile that is almost never discussed with patients.
SSRIs increase serotonin availability by blocking its reuptake into presynaptic neurons. Long-term, this creates downstream adaptations: receptor downregulation, altered gene expression, and — in some studies — increased amyloid-beta production. A 2019 study in PLOS ONE found that long-term SSRI use was associated with increased amyloid deposition in the brain, particularly in patients over 60. A 2020 meta-analysis in Ageing Research Reviews found that long-term SSRI use showed a rising dementia risk curve that becomes impossible to ignore past the five-year mark.
There's also the serotonin syndrome risk and the impact of chronic serotonin elevation on other neurotransmitter systems, including dopamine and acetylcholine. The brain doesn't operate with one neurotransmitter in isolation; altering serotonin indefinitely has cascading effects we are only beginning to understand.
The pattern is the same: prescribed short-term, used indefinitely. "Just in case" becomes five years, ten years, a lifetime. And the data from that duration of use is deeply uncomfortable.

7. Fluoroquinolone Antibiotics — Cipro (Ciprofloxacin), Levaquin (Levofloxacin)
Prescribed for: UTIs, sinus infections, respiratory infections
This one. This one makes me LIVID.
Fluoroquinolones are a class of antibiotics that were — and this is crucial — designed for serious, life-threatening infections. Pseudomonas pneumonia. Anthrax exposure. Complicated intra-abdominal infections where other antibiotics have failed. They are powerful drugs with a serious mechanism of action: they inhibit bacterial enzymes called topoisomerases (specifically DNA gyrase and topoisomerase IV) that are necessary for bacterial DNA replication.
The problem is that human mitochondria have their own version of these enzymes — because mitochondria are, evolutionarily, ancient bacteria that were incorporated into our cells. Fluoroquinolones don't only inhibit bacterial topoisomerases. They inhibit mitochondrial topoisomerases too.
Every single cell in your body — and especially your neurons, which are extraordinarily metabolically demanding — depends on mitochondria for energy. Damage mitochondrial DNA, impair mitochondrial enzyme function, and you are directly attacking the power supply of your brain cells. This is not theoretical. Fluoroquinolone-induced mitochondrial toxicity is documented in peer-reviewed literature going back to the early 2000s. Researchers have found evidence of mitochondrial damage in neuronal tissue following fluoroquinolone exposure.
The FDA issued a black box warning — the strongest warning possible — for fluoroquinolones in 2016, acknowledging "serious, disabling, and potentially irreversible" adverse effects including neurological side effects and psychiatric symptoms. The FDA has repeatedly strengthened its guidance, recommending that fluoroquinolones NOT be used as first-line treatment for uncomplicated UTIs, sinusitis, or bronchitis where safer alternatives exist.
And yet. They are still routinely prescribed for uncomplicated UTIs. For sinus infections. For ear infections. "Just take the Cipro, it'll clear it right up." Rapid cognitive decline, particularly in older adults, has been documented following fluoroquinolone treatment. The syndrome even has a name in patient communities: "floxing." Thousands of people have reported persistent neurological damage following a single course.
A single course.

The Pattern You Can't Ignore
After reading all seven, do you see it?
The pattern isn't that medicine doesn't have the data. It does. It's published. It's in the journals. The pattern is that the information never reaches the patient. That "as needed" becomes forever. That short-term tools become lifelong dependencies. That the brain — this extraordinary, irreplaceable organ that is the seat of everything you are — is treated as if it doesn't have specific needs, vulnerabilities, and limits.
Your brain needs:
Cholesterol to build and maintain cell membranes and myelin
Acetylcholine to form memories and maintain attention
B12 and folate to produce myelin and manage homocysteine
Mitochondria that are functioning and intact to power your neurons
A hippocampus that isn't shrinking from sedative drugs
A lysosomal system that can actually clear amyloid waste
Every single drug on this list interferes with one or more of those fundamental requirements. Some of them interfere with several at once.
The data is available. The studies are there. The system has them. And if you are taking any of these drugs — especially long-term — you deserve to know what they are doing to your brain. Not someday. Now.

What Can You Do?
The goal is to get off these drugs — with a plan, not a panic. Benzodiazepines and SSRIs in particular require a slow, supervised taper because the brain has physically adapted to their presence. Stopping cold turkey can cause serious physical symptoms. This isn't a reason to stay on them. It's a reason to find a practitioner who will actually help you come off them safely and address what's underneath.
What you can do right now:
Get honest about what you're taking. Write down every drug, how long you've been on it, and what it was originally prescribed for. Then ask: is that original reason still relevant? Was it ever addressed, or just covered up?
Find a root-cause practitioner. A functional medicine doctor, naturopath, or knowledgeable herbalist who will work with you on the underlying cause — not just refill the prescription.
Support your brain while you work on this. Certain herbs and nutrients have genuine, research-supported roles in brain protection and neuroplasticity: ginkgo biloba, bacopa monnieri, gotu kola, lion's mane mushroom, schisandra, and omega-3 fatty acids (particularly DHA) have peer-reviewed evidence for neuroprotective effects. B12 and folate sufficiency are non-negotiable. Real sleep — not the sedated unconsciousness that benzos produce — is how the brain clears amyloid waste through the glymphatic system.
Tell people you love. Your mother who takes Prilosec every day. Your friend who's been on Ambien for eight years. Your sister who takes Benadryl to sleep every night because she doesn't know there's a better option. Share this. Not to alarm people or make them feel terrible about what they've been doing — they didn't know. But now they can.

I started this company in 2018 because I was done watching people I loved get sicker under the care of a system that wasn't designed to make them well. Eight years later, I still feel the inadequacy every single day. The information I share reaches a tiny fraction of people, and I'm grateful for every one of them. But this information needs to reach everyone.
The drugs I've described above are not rare. They are in medicine cabinets all over this country right now. They are being taken by your parents, your friends, your neighbors — people who are trusting the system to protect them and likely even you.
The system is not protecting anyone on this one… or any other.
We have to.

Sources referenced in this article:
Gomm et al. (2016). Regular use of proton pump inhibitors and risk of dementia. JAMA Neurology.
Billioti de Gage et al. (2014). Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ.
Coupland et al. (2019). Anticholinergic drug exposure and the risk of dementia. JAMA Internal Medicine.
Gray et al. (2015). Cumulative use of strong anticholinergics and incident dementia. JAMA Internal Medicine.
FDA Black Box Warning Update for Fluoroquinolones (2016, 2018, 2023).
Diabetes Care (2019). Metformin use and vitamin B12 deficiency in type 2 diabetes.
This article is for educational purposes only. It is not medical advice. Please consult a qualified healthcare provider before making changes to any medication regimen.
